Opthea Limited (ASX:OPT)
Australia · Delayed Price · Currency is AUD 0.6000
0.00 (0.00%)
Mar 14, 2025, 4:10 PM AEST
Opthea Market Cap
Opthea has a market cap or net worth of 738.77 million as of March 18, 2026. Its market cap has increased by 61.54% in one year.
Market Cap
738.77M
Enterprise Value
885.55M
Revenue
-20.12K
Ranking
n/a
PE Ratio
2.59
Stock Price
0.60
Market Cap Chart
Since May 13, 1996, Opthea's market cap has increased from 39.30M to 738.77M, an increase of 1,779.68%. That is a compound annual growth rate of 10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 14, 2025 | 738.77M | -25.92% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.72B |
| Mesoblast | 2.65B |
| Neuren Pharmaceuticals | 1.46B |
| PYC Therapeutics | 1.38B |
| Clarity Pharmaceuticals | 1.35B |
| Clinuvel Pharmaceuticals | 493.47M |
| Racura Oncology | 401.65M |
| Tetratherix | 258.40M |